Charlie Heart ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  9.2% 16.5% 9.2% 15.2% 14.2%  
Credit score (0-100)  27 10 26 12 15  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  105 262 386 0 0  
Gross profit  12.9 -20.2 30.4 -0.4 129  
EBITDA  12.9 -20.2 30.4 -9.6 129  
EBIT  2.3 -30.9 20.7 -26.6 109  
Pre-tax profit (PTP)  1.9 -32.4 17.2 -32.9 99.5  
Net earnings  1.0 -25.1 14.2 -26.4 78.3  
Pre-tax profit without non-rec. items  1.9 -32.4 17.2 -32.9 99.5  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  47.5 36.9 60.4 43.5 150  
Shareholders equity total  136 111 125 98.7 177  
Interest-bearing liabilities  15.1 29.0 131 144 119  
Balance sheet total (assets)  168 149 266 263 339  

Net Debt  -6.6 -13.0 88.1 140 98.5  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  105 262 386 0 0  
Net sales growth  -40.3% 149.8% 47.3% -100.0% 0.0%  
Gross profit  12.9 -20.2 30.4 -0.4 129  
Gross profit growth  -85.5% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 1 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% -100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  168 149 266 263 339  
Balance sheet change%  -11.6% -11.0% 78.0% -1.2% 29.1%  
Added value  12.9 -20.2 30.4 -16.9 128.7  
Added value %  12.3% -7.7% 7.9% 0.0% 0.0%  
Investments  26 -21 14 -34 87  

Net sales trend  -1.0 1.0 2.0 -1.0 0.0  
EBIT trend  4.0 -1.0 1.0 -1.0 1.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  12.3% -7.7% 7.9% 0.0% 0.0%  
EBIT %  2.2% -11.8% 5.4% 0.0% 0.0%  
EBIT to gross profit (%)  17.6% 152.5% 68.1% 7,293.2% 84.8%  
Net Earnings %  0.9% -9.6% 3.7% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  11.0% -5.5% 6.2% 0.0% 0.0%  
Pre tax profit less extraordinaries %  1.9% -12.4% 4.4% 0.0% 0.0%  
ROA %  1.4% -19.5% 10.0% -9.9% 36.5%  
ROI %  1.6% -21.2% 10.5% -10.5% 40.6%  
ROE %  0.7% -20.3% 12.0% -23.6% 56.8%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  81.0% 74.2% 47.0% 37.6% 52.2%  
Relative indebtedness %  30.4% 14.7% 36.5% 0.0% 0.0%  
Relative net indebtedness %  9.7% -1.3% 25.4% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -50.8% 64.2% 289.9% -1,451.7% 76.5%  
Gearing %  11.1% 26.1% 104.6% 146.4% 67.0%  
Net interest  0 0 0 0 0  
Financing costs %  5.2% 6.9% 4.4% 4.8% 7.9%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  2.4 1.5 0.6 0.2 0.4  
Current Ratio  3.8 2.9 1.5 1.3 1.2  
Cash and cash equivalent  21.6 42.0 42.8 4.5 20.1  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  108.7 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  114.8% 43.0% 53.3% 0.0% 0.0%  
Net working capital  88.5 74.1 64.7 55.2 29.0  
Net working capital %  84.4% 28.3% 16.8% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -17 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -10 0  
EBIT / employee  0 0 0 -27 0  
Net earnings / employee  0 0 0 -26 0